Veterinary Vaccines Market Size, Share, Opportunities And Trends By Vaccine Type (Livestock Vaccines, Companion Animals Vaccines), By Technology (Live, Attenuated Vaccine, Inactivated/Killed Vaccine, Toxoid (Inactive Toxin) Vaccine, Subunit/Conjugate Vaccine) And Geography - Forecasts From 2019 To 2024

Published:  May 2021 Report Code: KSI061611783 Pages: 114
The veterinary vaccines market is projected to grow at a CAGR of 5.79% to reach US$9.279 billion by 2024, from US$6.620 billion in 2018. Increasing adoption of animal companions coupled with the growing incidence of animal diseases fuels up the growth of the market. Growth in the live stocks population and increasing initiatives by the government along with the involvement of animal associations widen up the market growth opportunities. Moreover, there is also a growing awareness of animal health with works as the key driver for the growth in the market. Apart from these factors, the high storage cost of vaccines acts as a restraint for the market.
 
This research study examines the current market trends related to demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
 
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases, and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top-down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the veterinary vaccine value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining a faster and more efficient understanding of the veterinary vaccines market.
 
The major players profiled in the veterinary vaccines market include Elanco, Zoetis, Ceva, Merck Animal Health, and Phibro Animal Health among others.
 
Segmentation
The veterinary vaccines market has been analyzed through the following segments:
 
By Vaccine Type
Livestock Vaccines
Companion Animals Vaccines
 
By Technology
Live, Attenuated Vaccine
Inactivated/Killed Vaccine
Toxoid (Inactive Toxin) Vaccine
Subunit/Conjugate Vaccine
 
By Geography
North America
USA
Canada
Mexico
 
South America
Brazil
Argentina
Others
 
Europe
Germany
France
United Kingdom
Others
 
Middle East and Africa
 
Asia Pacific
China
Japan
India
Others
1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY  
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. VETERINARY VACCINES MARKETBY VACCINE TYPE
5.1. Livestock Vaccines
5.2. Companion Animal Vaccines
6. VETERINARY VACCINES MARKET BY TECHNOLOGY
6.1. Live, Attenuated Vaccine
6.2. Inactivated/Killed Vaccine
6.3. Toxoid (Inactive Toxin) Vaccine
6.4. Subunit/Conjugate Vaccine
7. VETERINARY VACCINES MARKET BY GEOGRAPHY
7.1. North America
7.1.1. USA
7.1.2. Canada
7.1.3. Mexico
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. Germany
7.3.2. France
7.3.3. United Kingdom
7.3.4. Others
7.4. Middle East and Africa
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. Others
8. COMPETITIVE INTELLIGENCE
8.1. Competitive Benchmarking and Analysis
8.2. Recent Investments and Deals
8.3. Strategies of Key Players
9. COMPANY PROFILES
9.1. Elanco 
9.2. Zoetis
9.3. Ceva
9.4. Merck Animal Health
9.5. Phibro Animal Health
9.6. Virbac
9.7. Hester
9.8. Tianjin Ringpu
9.9. Hipra 
9.10. IdtBiologika
9.11. Jinyu Bio-Technology
LIST OF FIGURES
LIST OF TABLES
Elanco 
Zoetis
Ceva
Merck Animal Health
Phibro Animal Health
Virbac
Hester
Tianjin Ringpu
Hipra 
IdtBiologika
Jinyu Bio-Technology
 

Pricing

Explore Custom Options available with this study:

  •  Request customization
  •  Buy sections of the study
  •  Buy country specific report
  •  Request excel, Historical data
  •  Subscription inquiry
  •  Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.


Confidentiality

We are in compliance with the global privacy laws.